COPD flare-ups: symptoms and results
Part of Lungs & breathing clinical trials.
This study looks at people with COPD who have a sudden worsening of symptoms, called an exacerbation. It tracks what symptoms they have and how they do over time to help doctors understand better how to treat these episodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have COPD that was diagnosed by a doctor using standard guidelines.
- You are currently having a sudden worsening of your COPD symptoms, known as an exacerbation.
- You do NOT have stable COPD (your symptoms must be getting worse).
- You do NOT have asthma or a lung condition called bronchiectasis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at factors that can predict when chronic obstructive pulmonary disease (COPD) will flare up. It may help doctors identify people at higher risk sooner and tailor care to prevent flare-ups.
This study is for people with COPD who go to the emergency room for a moderate or severe flare-up. It looks at how they are doing after their visit and whether their current inhaler treatment is working well.
This study follows people with COPD flare-ups (sudden worsening of breathing) to better understand what happens and what might help. You may be asked for consent and lung-function tests if you meet the breathing and age requirements.
This study looks at people hospitalized for a COPD flare-up (“exacerbation”). It may help improve how flare-ups are treated because participants need to receive the usual rescue medicines like steroids and/or antibiotics and then follow a study plan.
This trial is looking at patients with a serious worsening of their chronic obstructive pulmonary disease (COPD) who need intensive care. It aims to gather information to help improve treatment for these severe episodes.
This observational study collects information on people with COPD (chronic lung disease) who have a severe flare requiring ICU care. It does not test a new drug, but the data may help doctors better understand severe COPD episodes and ICU outcomes.
Hear when a new Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.